Hosted on MSN18h
GLP-1 Drugs and Colonoscopy; GI Symptoms Post-COVID; Identifying High-Risk Barrett's
A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
'Gut-on-chip' can predict immunotherapy outcomes for melanoma patients
A team of researchers has developed a "gut-on-chip" (a miniature model of the human intestine on a chip-sized device) capable ...
GlobalData on MSN5d
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...